ZKIN vs OCG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 26, 2026

ZKIN

43.6
AI Score
VS
OCG Wins

OCG

55.1
AI Score

Investment Advisor Scores

ZKIN

44score
Recommendation
HOLD

OCG

55score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ZKIN OCG Winner
Revenue 71.24M 1.89M ZKIN
Net Income -3.99M -3.86M OCG
Gross Margin 5.7% 85.7% OCG
Net Margin -5.6% -204.2% ZKIN
Operating Income -4.25M -3.84M OCG
ROE -16.3% -6.0% OCG
ROA -6.3% -5.8% OCG
Total Assets 62.87M 66.53M OCG
Cash 2.31M 32.32M OCG
Current Ratio 1.44 30.14 OCG

Relative Price Performance (Last 90 Days)

ZKIN 1M: -11.8% · 3M: -17.8% OCG 1M: -1.2% · 3M: -2.9%

Current Technical Phase

ZKIN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.2%), weak momentum, RSI 39

RSI (14): 39.4 · Price: $1.20

OCG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.7 · Price: $1.68

Fundamentals Snapshot

Metric ZKIN OCG
Market Cap
Forward P/E 0.0 0.0
Trailing P/E
Revenue (TTM)
Revenue Growth -0.4% 9.0%
Gross Margin 0.1% 0.9%
Operating Margin -0.1% 0.4%
EPS -0.70 -25.66
Dividend Yield 0.00%

Frequently Asked Questions

Based on our detailed analysis, OCG is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.